Treatment of primary liver cancer by ultrasound guided percutaneous liver injection

Xiaodong HOU,Yuanbo PENG,Jun WU,Wei LEI,Fan ZHANG,Yingying YANG,Zhijun ZHAO
2018-01-01
Journal of Medical Imaging
Abstract:Objective To study the treatment of primary liver cancer by ultrasound guided percutaneous liver injection. Methods 78 cases of primary liver cancer diagnosed by pathological biopsy were selected in our hospital randomly. We observed the liver function of all patients before and after treatment,AFP,tumor size,survival time and analyzed the clinical efficacy of ul-trasound-guided percutaneous ethanol injection and 5-fluorouracil sustained release agent in the treatment of primary liver cancer. Results In comparison to 6 patients with primary liver cancer treated with percutaneous liver puncture and sustained release for a period of 3 months,the liver function of patients was significantly improved,and the AFP value was significantly reduced( P <0.01). 8 patients' tumor disappeared after treatment for 6 months,62 patients were treated with tumor diameter narrowing and blurred boundaries,5 patients were treated with clear boundary. The half year survival rate was 94.9%(74/78), the one year survival rate was 64.1%(50/78),the three year survival rate was 19.2%(15/78) after the treatment. Conclusion The treat-ment of primary liver cancer by ultrasound guided percutaneous ethanol injection and 5-fluorouracil sustained release agent had re-liable clinical efficacy,and the operation was convenient,safe,fast,so it should be vigorously promoted clinically.
What problem does this paper attempt to address?